Adam Valcek

Dr. Adam Valcek

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2023 in Microbiology Spectrum
Verified
Journal Article
Open access
AVAdam Valcek
Adam Valcek
CPChantal Philippe
Chantal Philippe
CWClémence Whiteway
Clémence Whiteway
EREtienne Robino
Etienne Robino
KNKristina Nesporova
Kristina Nesporova
CHCharles Van der Henst
Charles Van der Henst
Acinetobacter baumannii is a bacterium prioritized by the CDC and WHO because of its increasing antibiotic resistance, leading to treatment failures. The hallmark of this pathogen is the high heterogeneity observed among isolates, due to a very dynamic genome.

23 December 2021 in The ISME Journal
Verified
Journal Article
Open access
PDF file
CWClémence Whiteway
Clémence Whiteway
AVAdam Valcek
Adam Valcek
CPChantal Philippe
Chantal Philippe
MSMojca Strazisar
Mojca Strazisar
TPTim De Pooter
Tim De Pooter
CHCharles Van der Henst
Charles Van der Henst
We identify a new mechanism mediating capsule production and virulence in the WHO and CDC priority ESKAPE pathogen Acinetobacter baumannii. Non-capsulated and avirulent bacteria can revert into a capsulated and virulent state upon scarless excision of an ISAba13 insertion sequence under stress conditions. Reversion events fully restore capsule production and in vivo virulence. This increases our knowledge about A. baumannii genome dynamics, and the regulation of capsule production, virulence and resistance.

20 September 2022 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
AVAdam Valcek
Adam Valcek
KNKristina Nesporova
Kristina Nesporova
CWClémence Whiteway
Clémence Whiteway
TPTim De Pooter
Tim De Pooter
WCWouter De Coster
Wouter De Coster
CHCharles Van der Henst
Charles Van der Henst
In this study, we characterize a new collection that comprises multidrug-resistant (MDR), extensively drug-resistant (XDR), pandrug-resistant (PDR), and carbapenem-resistant modern clinical isolates of Acinetobacter baumannii collected from hospitals through national microbiological surveillance in Belgium. Bacterial isolates ( n = 43) were subjected to whole-genome sequencing (WGS), combining Illumina (MiSeq) and Nanopore (MinION) technologies, from which high-quality genomes (chromosome and plasmids) were de novo assembled.

26 July 2022 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Closed access
PDF file
JPJana Palkovicova
Jana Palkovicova
ISIva Sukkar
Iva Sukkar
JDJavier Delafuente
Javier Delafuente
AVAdam Valcek
Adam Valcek
MMMatej Medvecky
Matej Medvecky
MDMonika Dolejska
Monika Dolejska
To investigate the fitness effects of large blaCTX-M-15-harbouring F2:A1:B− plasmids on their native Escherichia coli ST131 H30Rx hosts. We selected five E. coli ST131 H30Rx isolates of diverse origin, each carrying an F2:A1:B− plasmid with the blaCTX-M-15 gene. The plasmid was eliminated from each isolate by displacement using an incompatible curing plasmid, pMDP5_cureEC958. WGS was performed to obtain complete chromosome and plasmid sequences of original isolates and to detect chromosomal mutations in ‘cured’ clones. High-throughput competition assays were conducted to determine the relative fitness of cured clones compared with the corresponding original isolates. We were able to successfully eliminate the F2:A1:B− plasmids from all five original isolates using pMDP5_cureEC958. The F2:A1:B− plasmids produced non-significant fitness effects in three isolates and moderate reductions in relative fitness (3%–4%) in the two remaining isolates. We conclude that F2:A1:B− plasmids pose low fitness costs in their E. coli ST131 H30Rx hosts. This plasmid-host fitness compatibility is likely to promote the maintenance of antibiotic resistance in this clinically important E. coli lineage.

7 March 2022 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
AJAnna Jozefíková
Anna Jozefíková
AVAdam Valcek
Adam Valcek
KSKatarina Soltys
Katarina Soltys
ENElena Nováková
Elena Nováková
Helena BujdákováHelena Bujdáková
Helena Bujdáková

1 January 2022 in Database: The Journal of Biological Databases and Curation
Verified
Journal Article
Open access
PDF file
AVAdam Valcek
Adam Valcek
JCJames Collier
James Collier
ABAlexander Botzki
Alexander Botzki
CHCharles Van der Henst
Charles Van der Henst
Acinetobacter baumannii is one of the most problematic nosocomial pathogens that can efficiently thrive within hospital settings, mainly due to resistances toward antibiotics, desiccation, disinfectants, human serum and oxidative stress. Recently, increased resistance against last-resort antibiotics earns this bacterium the highest priority concern classified by the Centers for Disease Control and Prevention and the World Health Organization. An obvious hallmark of this bacterium is the high heterogeneity observed among A. baumannii isolates, with a limited core genome. This feature complexifies the study of A. baumannii bacteria as an entity, subsequently reflected in a diversity of phenotypes of not only antimicrobial and environmental resistance but also virulence. A high degree of genome plasticity, along with the use of a limited subset of established strains, can lead to strain-specific observations, decreasing the global understanding of this pathogenic agent. Phenotypic variability of A. baumannii strains is easily observable such as with the macrocolony morphologies, in vitro and in vivo virulence, natural competence level, production of different capsular polysaccharide structures and cellular densities. Some strains encode several virulence factors, while others, including the established strains, lack key ones. The lack/excess of genes or specific physiological processes might interfere with in vivo and in vitro experiments, thus providing a limited impact on the global understanding of Acinetobacter bacteria. As an answer to the high heterogeneity among A. baumannii strains, we propose a first comprehensive database that includes the bacterial strains and the associated phenotypic and genetic data. This new repository, freely accessible to the entire scientific community, allows selecting the best bacterial isolate(s) related to any biological question, using an efficient and fast exchange platform. Database URL: https://acinetobase.vib.be/